| abstract |
Disclosed herein are peptides that inhibit the enzymatic activity of tyrosinase, as well as agents and methods for use thereof in reducing skin pigmentation, and methods of administering inhibitory peptides in topical formulations. The peptides are characterized by RADRADC and PLG-OH sequences. Methods of treating skin are also provided, which further comprise the use of peptides characterized by the amino acid sequence SFLLRN. |